AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Vizient Applauds House Judiciary Committee for Advancing CREATES Act, and other Drug Pricing Legislation

May 2, 2019

IRVING, Texas--(BUSINESS WIRE)--May 2, 2019--Vizient  commends the House Judiciary Committee for advancing the CREATES Act, and three other pieces of bipartisan legislation designed to promote competition and lower drug prices.

Vizient has strongly supported the CREATES Act, which will take needed steps to support generic manufacturers market access to needed samples that will help to bolster generic competition.

“We are pleased to see the House Judiciary Committee advance the CREATES Act and other bipartisan bills aimed at lowering drug prices,” said Shoshana Krilow, vice president of public policy and government relations for Vizient. “We thank the House committee for their action and urge Congress to quickly approve this important legislation so patients and hospitals can gain access to less-costly essential medications.”

Vizient is the nation’s largest health care performance improvement company serving a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health care delivery networks and non-acute health care providers.

About Vizient, Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents approximately $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as MedAssets’ Spend and Clinical Resource Management (SCM) segment, including Sg2, which was acquired in 2016. In 2019, Vizient again received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit  www.vizientinc.com  as well as our  newsroomblogTwitterLinkedIn  and  YouTube  pages for more information about the company.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190502005672/en/

CONTACT: Angie Boliver

(972) 830-7961

angie.boliver@vizientinc.com

KEYWORD: UNITED STATES NORTH AMERICA TEXAS

INDUSTRY KEYWORD: PRACTICE MANAGEMENT HEALTH HOSPITALS PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM CONGRESSIONAL NEWS/VIEWS PHARMACEUTICAL OTHER POLICY ISSUES MEDICAL SUPPLIES

SOURCE: Vizient

Copyright Business Wire 2019.

PUB: 05/02/2019 12:33 PM/DISC: 05/02/2019 12:33 PM

http://www.businesswire.com/news/home/20190502005672/en

All contents © copyright 2019 The Associated Press. All rights reserved.